Adq. Anual Farmacos 6
el Instituto Nacional del Cáncer requiere contratar el suministro de los Fármacos 6 necesarios para el óptimo funcionamiento de los servicios clínicos.
22 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 359-3811-SE15 | 31-12-2015 | Abbvie Productos Farmaceuticos Limitada | $228.480 |
| 359-3817-SE15 | 31-12-2015 | Productos Farmoquimicos Roche Limitada | $28.060 |
| 359-3816-SE15 | 31-12-2015 | Synthon Chile Limitada | $14.280 |
| 359-3815-SE15 | 31-12-2015 | Pfizer Chile S.A. | $1.332.800 |
| 359-3814-SE15 | 31-12-2015 | Novartis Chile S.A. | $313.160 |
| 359-3813-SE15 | 31-12-2015 | Icu Medical Chile Limitada | $71.400 |
| 359-3587-SE15 | 05-12-2015 | Novartis Chile S.A. | $128.948 |
| 359-3590-SE15 | 05-12-2015 | Salles Zapata y Compania Limitada | $53.550 |
| 359-3591-SE15 | 05-12-2015 | Laboratorio Sanderson S.A. | $795.408 |
| 359-3592-SE15 | 05-12-2015 | Synthon Chile Limitada | $14.280 |
| 359-3593-SE15 | 05-12-2015 | Tecnofarma S.A. | $2.738.095 |
| 359-3582-SE15 | 05-12-2015 | Abbvie Productos Farmaceuticos Limitada | $2.056.320 |
| 359-3583-SE15 | 05-12-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $321.300 |
| 359-3584-SE15 | 05-12-2015 | Icu Medical Chile Limitada | $142.800 |
| 359-3585-SE15 | 05-12-2015 | Inversiones Pmg S.A. | $41.650 |
| 359-3586-SE15 | 05-12-2015 | Libra Chile S.A. | $1.767.150 |
| 359-3588-SE15 | 05-12-2015 | Pfizer Chile S.A. | $5.599.664 |
| 359-3589-SE15 | 05-12-2015 | Productos Farmoquimicos Roche Limitada | $1.522.534 |
| 359-3267-SE15 | 18-11-2015 | B Braun Medical SpA | $858.585 |
| 359-3245-SE15 | 13-11-2015 | Productos Farmoquimicos Roche Limitada | $1.414.434 |
| 359-3235-SE15 | 12-11-2015 | Laboratorio Sanderson S.A. | $471.728 |
| 359-3234-SE15 | 12-11-2015 | Salles Zapata y Compania Limitada | $53.550 |
| 359-3232-SE15 | 12-11-2015 | Pfizer Chile S.A. | $4.096.932 |
| 359-3231-SE15 | 12-11-2015 | Libra Chile S.A. | $2.945.250 |
| 359-3229-SE15 | 12-11-2015 | Icu Medical Chile Limitada | $71.400 |
| 359-3228-SE15 | 12-11-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $576.255 |
| 359-3227-SE15 | 12-11-2015 | Abbvie Productos Farmaceuticos Limitada | $1.904.000 |
| 359-3236-SE15 | 12-11-2015 | Tecnofarma S.A. | $657.975 |
| 359-2792-SE15 | 05-10-2015 | Astrazeneca S.A. | $330.820 |
| 359-2796-SE15 | 05-10-2015 | Laboratorio Sanderson S.A. | $93.296 |
| 359-2795-SE15 | 05-10-2015 | Productos Farmoquimicos Roche Limitada | $1.500.090 |
| 359-2794-SE15 | 05-10-2015 | Pfizer Chile S.A. | $1.713.600 |
| 359-2793-SE15 | 05-10-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $576.255 |
| 359-2791-SE15 | 05-10-2015 | Abbvie Productos Farmaceuticos Limitada | $1.523.200 |
| 359-2436-SE15 | 01-09-2015 | Synthon Chile Limitada | $14.280 |
| 359-2429-SE15 | 01-09-2015 | Abbvie Productos Farmaceuticos Limitada | $2.665.600 |
| 359-2430-SE15 | 01-09-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $1.213.643 |
| 359-2431-SE15 | 01-09-2015 | Icu Medical Chile Limitada | $71.400 |
| 359-2432-SE15 | 01-09-2015 | Libra Chile S.A. | $589.050 |
| 359-2433-SE15 | 01-09-2015 | Pfizer Chile S.A. | $6.037.584 |
| 359-2434-SE15 | 01-09-2015 | Productos Farmoquimicos Roche Limitada | $991.794 |
| 359-2435-SE15 | 01-09-2015 | Laboratorio Sanderson S.A. | $132.209 |
| 359-2135-SE15 | 11-08-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $509.910 |
| 359-1813-SE15 | 11-08-2015 | Salles Zapata y Compania Limitada | $53.550 |
| 359-2133-SE15 | 11-08-2015 | Abbvie Productos Farmaceuticos Limitada | $4.188.800 |
| 359-2134-SE15 | 11-08-2015 | Astrazeneca S.A. | $165.410 |
| 359-2142-SE15 | 11-08-2015 | Synthon Chile Limitada | $14.280 |
| 359-2141-SE15 | 11-08-2015 | Laboratorio Sanderson S.A. | $201.491 |
| 359-2140-SE15 | 11-08-2015 | Productos Farmoquimicos Roche Limitada | $2.387.854 |
| 359-2138-SE15 | 11-08-2015 | Pfizer Chile S.A. | $8.090.477 |
| 359-2137-SE15 | 11-08-2015 | Novartis Chile S.A. | $626.321 |
| 359-2136-SE15 | 11-08-2015 | Libra Chile S.A. | $1.570.800 |
| 359-1811-SE15 | 28-07-2015 | Abbvie Productos Farmaceuticos Limitada | $3.046.400 |
| 359-1806-SE15 | 23-07-2015 | Astrazeneca S.A. | $165.410 |
| 359-1807-SE15 | 23-07-2015 | Glaxosmithkline Chile Farmaceutica Limitada | $703.733 |
| 359-1809-SE15 | 23-07-2015 | Novartis Chile S.A. | $460.530 |
| 359-1893-SE15 | 23-07-2015 | Laboratorio Sanderson S.A. | $199.087 |
| 359-1817-SE15 | 23-07-2015 | Icu Medical Chile Limitada | $71.400 |
| 359-1816-SE15 | 23-07-2015 | B Braun Medical SpA | $117.513 |
| 359-1815-SE15 | 23-07-2015 | Productos Farmoquimicos Roche Limitada | $633.794 |
| 359-1814-SE15 | 23-07-2015 | Pfizer Chile S.A. | $9.110.640 |
| 359-1812-SE15 | 23-07-2015 | Libra Chile S.A. | $1.767.150 |
| 359-1810-SE15 | 23-07-2015 | Synthon Chile Limitada | $14.280 |
Fuente original:ficha mercadopublico.cl